24Oct
28Sep
Wasabi Technologies Reaches Unicorn Status
Boston, MA September 27th, 2022, Boston Harbor Angels (BHA) is pleased to announce that Wasabi Technologies, one of its portfolio companies, has reached Unicorn status with the close of $250M round of investment. “We are very happy for Wasabi Technologies, investors and Wasabi employees,” says Ziad Moukheiber, President and CEO of Boston Harbor Angels. “David Friend, Founder and CEO of Wasabi Technologies is an exceptional entrepreneur. BHA is thrilled to have been part of this journey from the beginning...
15May
A Founder Focused Approach
We focus on and celebrate Boston Harbor Angels Founders! A seasoned serial founder once said, "If it feels easy it means you are doing something wrong" , building a business and being accountable to investors is very hard and that is why the success and exit rates are so low. Aligning yourself with the right #AngelInvestors is key and keeping them updated makes the journey much simpler. Angels are here to help! Boston Harbor Angels fund and support dozens of Founders! There is nothing more...
19Jan
Boston Harbor Angels to Expand to Miami
Boston Harbor Angels to Expand to Miami
January 18, 2022, Boston, MA: Boston Harbor Angels, Inc (BHA), a leading Boston-based angel investment group, announced today that it is opening a Miami presence of BHA. Ziad Moukheiber, President and CEO of BHA said, “We are very excited to have a presence in Miami and to collaborate with local investors and entrepreneurs to continue the BHA brand of investing for a better world.” BHA will extend its long and fruitful collaboration with Babson College...
07Jan
Read more...
24Dec
Read more...
02Sep
10 PORTFOLIO COMPANIES TO WATCH IN 2022
10 portfolio companies to watch in 2022 selected by Ziad Moukheiber President Boston Harbor Angels. The list is in alphabetical order /Akston Bioscienceshttps://www.akstonbio.com/
Archer Roosehttps://archerroose.com/
Astrocyte Pharmaceuticalshttps://www.astrocytepharma.com/
Cytoagentshttps://www.cytoagents.com/
Futurefuel.iohttps://futurefuel.io/
Revbiohttps://revbio.com/
S'Morehttps://www.smoredate.com/
Wasabi Technologieshttps://wasabi.com/
Winter Innovationshttps://www.winter-innovations.com/
Xeno Bioscienceshttps://www.xenobiosciences.com/
11Aug
Boston Harbor Angels leads Xeno Biosciences $7.25M Series A Round
Somerville, MA, Aug 8, 2021 – Xeno Biosciences Inc., a clinical stage drug discovery and development company advancing therapeutics for the treatment of obesity and metabolic diseases, announced today the completion of the Company’s Series A financing, which raised $7.25M in a private round. The investment round was led by Boston Harbor Angels and was joined by a syndicate of individuals and groups including Clinical Research Ventures, Maine Angels, Bangor Angels, Dirigo Angels, Santa Barbara Angels, Beacon Angels, SideCar Angels, NOLA...
04Aug
Read more...
29Jun